(ü 404) |
|
|
|
|
[] WFH 2020 ̽þ ˶Ǫ ȸ, ȹ
쿬(World Federation of Hemophilia, WFH) 6 14Ϻ 17ϱ ̽þ ˶Ǫ 2020 WFH ȸ ϰų ȹ Ȩ .
Ȳ
2020-03-06
|
|
|
|
|
[] ȯ ?
캴 ȯ ȯ ϴ 22% ȸϴ Ÿ.쿬(WFH) ǥ 2018 ʺ(Annual Global Survey) ϸ, 캴 ôü ȯ
2020-02-23
|
|
|
|
|
[] Ư 캴 ü ?
, 9 ü 캴B Ҿȯ ü ־ Ư ߴ ͺ Ÿ. Haematologica ο 캴B ȯ ü : PedN
Ȳ
2020-02-02
|
|
|
|
|
[] ǰ ÿ.. ӻ ǥ
(Hemlibra, и emicizumab, ػ) 캴A ȯ ǰ Ű Ÿ. ̱ ÷θ ÷ ̱
Ȳ
2020-01-28
|
|
|
|
|
[] 캴 ġῡ 35? 캴 A ġ ǥ
̿(BioMarin) 캴A ġ Valrox(valoctocogene roxaparvovec) 2鸸 ( 23 3õ) 3鸸 ( 34 9õ 5鸸) ι ȹ̶ .
Ȳ
2020-01-28
|
|
|
|
|
[] ʷ̼ ̿, AAV ο ġ
ʷ̼ ̿(Generation Bio) 캴 A Ÿ ȯ ġḦ ̷ ġ ο ӻ 1 1õ ( 1,128) ڱ Ѵٰ .
Ȳ
2020-01-22
|
|
|
|
|
[] ASC , 캴 A ġ α
ASC (ASC Therapeutics) 캴 A ġ α ̷ ġ ӻ ÷ ϱ ̿̾(Vigene Biosciences) ϰ ִٰ
Ȳ
2020-01-17
|
|
|
|
|
[] ȭ, ġ SB-525 μϿ 3
(Sangamo Therapeutics) 캴 A ġ SB-525 ȭ(Pfizer) 絵, 3 ӻ ġ ̶ . ȭ
Ȳ
2020-01-11
|
|
|
|
|
|
|
[] Ǵٽ λϴ ġ , ϼ
캴 ġῡ ־ ġ ġ 캴 ȯڵ ġ ǰ ʰ ư ӵ ұϰ ġ 輺 ʰ ִ. ġῡ Ǵ ,
Ȳ
2020-01-10
|
|
|
|
|
[] 11 ӻ, 輺
Ͽ ִ ̽ (Beth Israel Deaconess Medical Center) (postpartum hemorrhage, PPH) 11(FXI) ִ
Ȳ
2020-01-03
|
|
|
|
|
[] ̾ & ɴ, ͱ
̾(Enzyre) 캴ġ 갳߱ ɴ(Takeda) Ͽ 캴 ȯڰ ϰ ¸ Ȯ ִ ġ ϰ ִٰ . ״ ȸ ̾ ɴٷκ е(
Ȳ
2019-12-27
|
|
|
|
|
[] ɴ, Adynovate Feiba ǻ
ɴ(Takeda) ֱ ÷θ ÷ 61 2019 ̱ȸ(American Society of Hematology, ASH) ȸǿ 캴 ȯ ġῡ ־ ȿ ϴ
Ȳ
2019-12-24
|
|
|
|
|
[] ɴ, 캴 ġ ȿ ü ʱ ǥ
ɴ(Takeda) 캴 ġῡ ɸ Ǵ ̷ Ϳ 鿪 ʱ ǥϿ. ̴ 7Ϻ 10ϱ ̱ ÷ 61 ̱ȸ(American Society
Ȳ
2019-12-19
|
|
|
|
|
[] ȯ Բ, I can do!
ְ ִ ȯڵ ǰ Ȱ ȭ Ű ȸ ɴ(Takeda) (Virgin Pulse) Բ 900 ȯڵ ϰ ۷ι ç Ȱ(Virgin Pulse Global Ch
Ȳ
2019-12-19
|
|
|
|
|
[] 'Դ 캴 ġ' ô ?
̿(Bayer) ̱ ʶǾ Ƶ Բ ʷ 캴 A, B ȯڸ δ Һ 汸 ġ ϴ 3Ⱓ ߴٰ . 캴 A, B ġῡ
Ȳ
2019-12-18
|
|
|
|
|
[] [] ̱ȸ ʹõ '캴 FOCUSING'
7Ϻ 10ϱ ÷θ ÷ 61 ̱ȸ(American Society of Hematology = ASH) ʹ Ȳ Ǿ.ASH ʹ 쿬(WFH)ȸ, ȸ(ISTH)ȸ
2019-12-11
|
|
|
|
|
[] 캴 ȯ ̴ ȿ
FVIIa Ŀ 뷮 ־ִ αȭ ̴ 8 ü 캴 A ȯڿ ϴ Ǵ ڸ ߴٴ ǥǾ. ڵ ̴
Ȳ
2019-12-05
|
|
|
|
|
[] 2020 WFHȸ ʷ ߳?
2020 6 ̽þƿ 쿬(WFH)ȸ 1 ʷ ƴ.WFH 2020 ȸ ǥ ȯ ʷ 11 29 1 ߴٰ . ʷ ũ кι ι
2019-12-01
|
|
|
|
|
[] 뷮 ε ִ?
± 캴 Ƶ 'ġ'(µ) 8 뷮 Ģ Ǽҵ带 ̰ ϴµ ȿ̶ ǥߴ.
Ȳ
2019-11-29
|
|
|